tiprankstipranks
Trending News
More News >
Akero Therapeutics Inc (AKRO)
NASDAQ:AKRO
US Market

Akero Therapeutics (AKRO) Income Statement

Compare
639 Followers

Akero Therapeutics Income Statement

Last quarter (Q3 2025), Akero Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Akero Therapeutics's net income was $-81.57M. See Akero Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -29.00K$ 0.00$ 0.00$ -213.00K
Operating Expenses
$ 285.42M$ 172.87M$ 115.16M$ 100.89M$ 80.15M
Depreciation and Amortization
$ 18.00K$ 29.00K$ 43.00K$ 41.00K$ 213.00K
EBITDA
$ -247.37M$ -148.63M$ -111.25M$ -100.74M$ -78.99M
Operating Income
$ -285.42M$ -172.87M$ -115.16M$ -100.89M$ -80.15M
Other Income/Expenses
$ 33.36M$ 21.11M$ 3.12M$ 109.00K$ 947.00K
Pretax Income
$ -252.06M$ -151.76M$ -112.03M$ -100.78M$ -79.21M
Net Income
$ -252.06M$ -151.76M$ -112.03M$ -100.78M$ -79.19M
Per Share Metrics
Basic EPS
$ -3.75$ -2.89$ -2.87$ -2.89$ -2.52
Diluted EPS
$ -3.75$ -2.89$ -2.87$ -2.89$ -2.52
Weighted Average Shares Outstanding
67.14M 52.57M 38.98M 34.83M 31.46M
Weighted Average Shares Outstanding (Diluted)
67.14M 52.57M 38.98M 34.83M 31.46M
Currency in USD

Akero Therapeutics Earnings and Revenue History